000 | 01134 a2200313 4500 | ||
---|---|---|---|
005 | 20250516084857.0 | ||
264 | 0 | _c20121010 | |
008 | 201210s 0 0 eng d | ||
022 | _a1432-0878 | ||
024 | 7 |
_a10.1007/s00441-012-1377-9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBanno, Haruhiko | |
245 | 0 | 0 |
_aPathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy (SBMA). _h[electronic resource] |
260 |
_bCell and tissue research _cJul 2012 |
||
300 |
_a313-20 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBulbo-Spinal Atrophy, X-Linked _xdrug therapy |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeuprolide _xtherapeutic use |
650 | 0 | 4 | _aMolecular Targeted Therapy |
700 | 1 | _aKatsuno, Masahisa | |
700 | 1 | _aSuzuki, Keisuke | |
700 | 1 | _aTanaka, Fumiaki | |
700 | 1 | _aSobue, Gen | |
773 | 0 |
_tCell and tissue research _gvol. 349 _gno. 1 _gp. 313-20 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00441-012-1377-9 _zAvailable from publisher's website |
999 |
_c21678837 _d21678837 |